US Stock MarketDetailed Quotes
SBFMW SUNSHINE BIOPHARMA INC C/WTS (TO PUR COM)
- 0.053
- 0.0000.00%
Trading Jul 18 14:26 ET
0Market Cap0.00P/E (TTM)
0.000High0.000Low0Volume0.000Open0.053Pre Close0.00Turnover0.00%Turnover Ratio0.00P/E (Static)0Shares0.46152wk High0.00P/B0Float Cap0.03652wk Low--Dividend TTM0Shs Float7.600Historical High--Div YieldTTM0.00%Amplitude0.036Historical Low--Avg Price1Lot Size
About SUNSHINE BIOPHARMA INC C/WTS (TO PUR COM) Company
Sunshine Biopharma, Inc. is a pharmaceutical company, which engages in the research, development, and commercialization of oncology and antiviral drugs. It is also involved in the development and commercialization of science-based nutritional supplements. The firm's product includes treatment for Coronavirus infections and anticancer drugs. The company was founded on August 31, 2006 and is headquartered in Fort Lauderdale, FL.
Company Profile
SymbolSBFMW
Company NameSUNSHINE BIOPHARMA INC C/WTS (TO PUR COM)
Listing DateFeb 15, 2022
Founded2006
CEODr. Steve N. Slilaty, PhD
MarketNASDAQ
Employees44
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address333 Las Olas Way,CU4 Suite 433
CityFort Lauderdale
ProvinceFlorida
CountryUnited States of America
Zip Code33301
Phone1-945-515-0810
Company Executives
- Name
- Position
- Salary
- Dr. Steve N. Slilaty, PhD
- President, Chief Executive Officer and Chairman of the Board
- 60.00K
- Marc Beaudoin
- Chief Operating Officer
- --
- Malek Chamoun, C.P.A.
- Chief Development Officer
- --
- Dr. Abderrazzak Merzouki, PhD
- Chief Science Officer and Director
- 60.00K
- Camille Sebaaly
- Principal Accounting Officer, Chief Financial Officer and Secretary
- 930.00K
- David Natan
- Independent Director
- 60.00K
- Dr. Rabi Kiderchah
- Independent Director
- 60.00K
- Dr. Andrew Keller
- Independent Director
- 60.00K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg